BTIG
Edit

BTIG

https://www.btig.com/
Last activity: 28.08.2026
Active
Categories: BrokerCorporateFinTechFirmInvestmentManagementPersonalResearchSalesService
BTIG is a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services. Located throughout the U.S., and in Europe, Asia and Australia, our professionals leverage their expertise to service clients at every stage of the investment lifecycle. Fueled by our passion to help maximize results for our institutional and corporate clients, BTIG offers personalized multi-asset class execution, expertise and insights worldwide across equities, equity derivatives, ETFs, fixed income, futures, commodities, foreign exchange, interest rates, credit, and convertible and preferred securities. The firm’s core capabilities include global sales, portfolio, electronic and outsource trading, transition management, investment banking, prime brokerage, capital introduction, corporate access, research and strategy, commission management and more.

With a team of seasoned industry experts, BTIG provides end-to-end solutions for a diverse global client base. As we look to unlock value and propel growth for clients, we are consistently capturing market share year after year. Committed to excellence, we are proud of our rich history of designing solutions that help our clients achieve their objectives.

For more information about BTIG, please visit www.btig.com.

Member of FINRA and SIPC.
Website visits
31.5K /mo.
Mentions
138
Location: United States, California, San Francisco
Employees: 501-1000
Founded date: 2005

Mentions in press and media 138

DateTitleDescription
28.08.2026Kazia Therapeutics Limited Announces Pricing of Up to $120 Million Public OfferingSYDNEY, Aug. 28, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing therapies that selectively reprogram cancer biology, restor...
28.08.2026Kazia Therapeutics Limited Announces Proposed Public OfferingSYDNEY, Aug. 28, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing therapies that selectively reprogram cancer biology, restor...
25.08.2026Bitcoin price extends gains, briefly tops $81,000 as crypto rally gathers paceBitcoin briefly surged past $81,000 as renewed inflows into spot bitcoin ETFs and improving risk appetite extended the cryptocurrency’s recent rally. The latest move extends a sharp rally that began last week, when bitcoin surged more than ...
24.08.2026Crypto extends gains after biggest 3-day rally since 2023Bitcoin and crypto stocks extended their rally to start the week after the flagship cryptocurrency broke out of its trading range as investor concern over inflation and the fiscal deficit grew. The price of bitcoin was higher by 2% on Monda...
17.08.2026‘Don’t get too comfortable’: Wall Street’s ‘fear gauge’ hits 2026 low — here’s why it’s unlikely to lastThe VIX, Wall Street’s so-called “fear gauge,” has dipped to its lowest level this year, as stock markets approach record highs. Analysts said that the VIX’s slide points to growing investor complacency, just as markets head into a traditio...
10.08.2026CrowdStrike, Palo Alto hit records after Black Hat cyber conference illuminates rising AI threatCybersecurity stocks CrowdStrike and Palo Alto Networks jumped to new highs following the industry’s Black Hat conference in Las Vegas. Analysts at BTIG wrote that “AI agents have fundamentally changed the threat landscape.” Businesses are ...
09.08.2026Daily Stock Market Live S&P 500 closes little changed as oil rises on Iran uncertainty, Intel leads chips lowerThe S&P 500 ended Monday just below the flatline amid growing doubts that the U.S. and Iran will come to a lasting resolution to the conflict in the near term. The broad index slipped 0.06% to end at 7,753.11, while the Nasdaq Composite...
01.08.2026ProLogium And Translational Development Acquisition Corp. Announce $50 Million Committed Primary Capital InvestmentPrologium Holding Inc. and Translational Development Acquisition Corp. have secured commitments for a $50 million primary capital investment from a consortium of existing ProLogium shareholders. The investment consists of $50 million of com...
31.07.2026Why Situational Awareness hedge fund imploded, even in a tame stock marketThe stock market looked unusually tranquil. Beneath the surface, one of Wall Street’s fastest-growing funds devoted to artificial intelligence investments was unraveling. In a matter of weeks, Leopold Aschenbrenner’s Situational Awareness w...
21.07.2026Reformation Launches IPO For Up To $239.1 Million At $15 To $17 Per ShareReformation has launched the roadshow for its initial public offering of 14,062,500 shares of common stock. The sustainable womenswear company expects the IPO to price between $15 and $17 per share, implying gross proceeds of approximately ...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In